AZERCABTAGENE ZAPRELEUCEL
UNII PFZ3AP93TA

Substance Identification & Data

This profile provides standardized clinical and technical data for Azercabtagene Zapreleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PFZ3AP93TA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PFZ3AP93TA

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AZERCABTAGENE ZAPRELEUCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C158558

National Cancer Institute reference terminology for clinical and research data.

INN ID

11438

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-134

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azercabtagene Zapreleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AZERCABTAGENE ZAPRELEUCEL

Common Names & Synonyms

ALLOGENEIC ANTI-HUMAN-CD19 CAR T CELL PRODUCT DERIVED FROM HEALTHY DONOR T CELLS THAT ARE GENETICALLY EDITED TO (A) REMOVE THE EXPRESSION OF THE ENDOGENOUS T CELL RECEPTOR (TCR) AND (B) INSERT AN ANTI-CD19 CAR GENE, THEREBY PROVIDING THE ABILITY TO SPECIFICALLY TARGET, BIND TO, AND KILL CD19+ CELLS.

AZERCABTAGENE ZAPRELEUCEL [INN]

AZERCABTAGENE ZAPRELEUCEL [USAN]

AZERCABTAGENE ZAPRELEUCEL [WHO-DD]